FDA.reportPublic FDA data

{3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack

RxCUI
2119388
RxNorm name
{3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack
Display name
{3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack
Full name
{3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack
Term type
GPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d81a6a79-a74a-44b7-822c-0dfa3036eaed{3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack [GPCK] · esketamine HCl 84 MG (28 MG x 3) Nasal Spray [PSN] · esketamine 140 MG/mL Nasal Spray (3- 0.2 OZ Pack) [SY]318These highlights do not include all the information needed to use SPRAVATO safely and effectively. See full prescribing information for SPRAVATO. SPRAVATO ® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine)20260313